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CHINESE REGULATION OF TRADITIONAL
CHINESE MEDICINE IN THE MODERN WORLD: CAN
THE CHINESE EFFECTIVELY PROFIT FROM ONE OF
THEIR MOST VALUABLE CULTURAL RESOURCES?
Teresa Schroeder
Abstract: The global demand for traditional Chinese medicine ("TCM") has
exploded in the last thirty years. Demand for TCM products increased both domestically
in the People's Republic of China ("PRC") and internationally. However, the stigma of
"witch doctoring" associated with TCM remains. Several developed nations have
established national and local regulation of TCM practitioners to protect their citizens
from dangerous treatments. After almost forty years of virtually unregulated
endorsement of TCM, China recently began its own standardization of TCM products
and practice. The question must be asked, what inspired such a dramatic and rapid
change in Chinese policy? The geyser of Chinese TCM regulation can largely be
attributed to a growing international demand for alternative medical treatments. China
realizes the potential profit of TCM trade, and recognizes comprehensive knowledge of
its own medicine creates an obvious advantage over other sources of TCM. However,
lack of standardization in products, outlandish advertising campaigns, and apprentice-
based training all contribute to many nations' unwillingness to allow the importation of
TCM from China. China's new TCM regulations respond directly to foreign countries'
concerns and display the PRC's determination to fully enter, and possibly dominate, the
global TCM market.
I. INTRODUCTION
The past thirty years have witnessed an explosion in global demand
for traditional Chinese medicine' ('TCM"). 2  Demand for TCM products
increased both within the People's Republic of China ("China" or "PRC")
and internationally. However, the stigma of "witch doctoring" associated
with TCM remains. Accordingly, several developed nations have regulated
TCM practitioners to protect their citizens from dangerous misdiagnosis and
mistreatment. China, itself, recently began to standardize TCM products
and practice. After almost forty years of virtually unregulated endorsement
' Chinese legal standards define TCM as involving the use of "traditional Chinese proprietary
medicines, the extract and preparation of medicinal herbs and processed traditional Chinese herbs,"
although more general definitions include treatments such as massage, acupuncture, and diagnosis systems.
See State Council of China, Regulations on Protection of Traditional Chinese Medicines Decree No. 106,
chap. 1 art. 2 (1992) (Cn.), www.chinalaw.com (english translation).
2 "Chinese medicine is used by more than 20% of the world's population." Donald I. Abrams &
Charles Steinberg, Complementary Therapies in HIV Disease, 4 IMPROVING THE MANAGEMENT OF HIV
DISEASE 3, (1996), reprinted in JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, at http://www.ama-
assn.org/special/hiv/treatment/updates/abrams.htm.
3 See infra Part III.A (discussing United States, Australian, and British regulations).
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of TCM, the national and local governments began a widespread effort to
standardize TCM products, education, and distribution, both domestically
and internationally. This Comment considers both the motivation for the
dramatic and rapid change in Chinese policy, and whether the regulations
can be effectively enforced.
Since 1949, Chinese political leaders have advocated the use of TCM
as medical care for the masses.4 The first research center for TCM was
established in 1955.5 However, not until the late 1980s and early 1990s did
China create any comprehensive regulation of TCM. Since the 1982
Chinese Constitution,6 the PRC, via the State Administration of Traditional
Chinese Medicine ("SATCM"), has promulgated 170 industrial rules
relating to TCM.7 Regulations in eleven local provinces and municipalities
supplement the national movement.
The geyser of Chinese TCM regulation can largely be attributed to a
growing international demand for alternative medical treatments. China
recognizes the potential profit of TCM trade. The comprehensive
knowledge of the Chinese regarding their own medicine creates an obvious
advantage over other sources of TCM. However, lack of standardization in
products, outlandish advertising campaigns, and apprentice-based training in
China all contribute to many nations' unwillingness to allow importation of
TCM from China. Therefore, while estimated international sales of herbal
medicine total $20 billion annually, China accounts for less than 3% of this
total. China's regulation of TCM directly responds to foreign countries'
concerns and is evidence of the PRC's determination to fully enter, and
possibly dominate, the global TCM market. Nonetheless, questions remain
concerning whether this attempt will be successful in the modem legal and
political climate of the PRC. Recent legislation and enforcement measures
indicate a real possibility of success, provided historic pitfalls in
enforcement and continuing international distrust can be alleviated.
Part II of this Comment discusses the basic history of TCM traditions,
products and practitioners. Part III analyzes international TCM practice,
4 See DAVID M. LAMPTON, THE PouTcs OF MEDICINE IN CHINA 21-44 (1977).
' Id. at63.
6 "The state develops medical and health services, promotes modem medicine and traditional
Chinese medicine . . to protect the people's health." XiANFA [Constitution of the People's Republic of
China] (1982) art. 21, translated in LEXIS.
Let Traditional Medicine Benefit All, July 28, 2000, http://www.china.org.cn (China Internet
Information Center is a government authorized portal managing a database of Chinese news articles
published under the auspices of the China International Publishing Group and the State Council
Information Office in Beijing).
s Nobel Laureate Calls for Modernization of Medicine, CHINA DAILY, Oct. 31, 2001,
http://www.chinadaily.com.cn
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standards, market pressures, and expectations. Part IV examines modem
China's TCM investment, legislation, practice, and education. Part V
concludes by examining the possible resolution of remaining barriers to
China's increasing role in the global TCM trade.
II. HISTORICAL BACKGROUND IN CHINA
The lack of regulation of TCM may be explained by its historic status
as a cultural institution.9 Simply stated, given the traditional use of TCM,
regulation of this facet of people's lives was unnecessary, even intrusive.
The Yellow Emperor's Classic provides the first recorded evidence of
widespread use of TCM in mainland China.' 0 This ancient text, written
prior to 85 B.C., details traditional methods of diagnosis and treatment."
Later written examples of traditional diagnosis and healing testify to China's
rich medical history, as well as to some correlation between the basic
theories and products used for treatment."
However, despite long use by the Chinese, there is little evidence of
uniformity in the preparation, ingredients, and dosage of traditional Chinese
medical treatments. The early records suggest there was no centralized
training or regulation of TCM practitioners. This variety and healer
discretion inherent in TCM bred widespread distrust of TCM within China
following the advent of Western medicine in the 1900s. 3 Lack of
standardization, scientific testing, and greater accessibility of new
technologies all contributed to a perception of TCM as uncivilized quackery.
The Chinese Revolution, headed by Mao Zedong, which achieved
victory in 1949, precipitated vigorous and open debate concerning TCM. In
1949, the Chinese Medical Association called for complete abolition of
TCM.14 The nation's leading doctors supported the scientifically based
advances of Western medicine and felt that TCM posed a serious danger to
the Chinese citizenry.' 5 Mao Zedong rejected this movement and urged the
recognition and support of Chinese medicine, specifically to treat the
9 Health Minister Vows Support for Traditional Chinese Medicine, CHINA DAiLY, Jan. 1, 2002,
http://www.chinadaily.com.cn
10 LAMPTON, supra note 4, at 3.
I1 Id.
12 See, e.g., id. at 3-5 (discussing the Yellow Emperor's Classic, Classic of Local Herbs, written in
206-222 A.D., as well as discoveries and records of the Sung, 907-1279 A.D., and Yuan, 1234-1368 A.D.,
dynasties).
13 Id. at47.
14 id.
15 id.
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millions living in rural areas. 16 In 1954, Mao Zedong reorganized the health
department to incorporate TCM.17 This directive spawned the largest state-
run TCM organization, China Academy of Traditional Chinese Medicine
("CATCM") that continues to educate TCM professionals today.'8
The Academy sprang from less than auspicious beginnings; in 1955 it
controlled only four five-year colleges for training in TCM. Despite lack of
support, the Academy directly challenged the Medical Association, and in
1958, the Central Committee directed all Western-trained doctors to take
three-month supplemental courses in TCM.19 TCM colleges increased to
thirteen by the end of 1958.20 TCM doctors began staffing the bulk of
commune clinics, providing the primary source of care for rural Chinese.
21
The popularity of TCM treatments grew. In the 1960s, the PRC, still
plagued by widespread disease, began a new medical campaign, the
"Barefoot Doctors", 22 championed largely by doctors who endorsed TCM
treatments. In 1949 China had 100,000 fully trained Western style doctors;
by the end of 1967 there were an additional 150,000 doctors. All doctors
were trained in accordance with the six to eight year educational standards
of United States and U.S.S.R.23  Secondary medical personnel with two to
four years of training increased to 500,000.24 The barefoot doctors existed
along the periphery of this second group. Training for barefoot doctors
reportedly varied from three months to ten months.25  However, by all
16 Id.
17 Id.
18 Opened on December 19, 1955, CATCM is currently comprised of eleven research institutions,
five clinical institutions, eight national specialization departments, and two national bases of clinical
pharmacology. LAMPTON, supra note 4, at 63; and Medboo, Training Center of China Academy of
Traditional Chinese Medicine, http://www.medboo.com/eng/catcm.htm (last visited Apr. 14, 2002)
(Medboo is a TCM training center working in conjunction with the China Academy of Traditional Chinese
Medicine to provide long distance training in TCM.).
19 LAMFTON, supra note 4, at 112.
2 Id. at 115.
21 Id at 113.
22 The "barefoot doctors" were common, rural citizens with basic medical training. Kenneth Levin,
Medicine & Chinese Society, in MODERN CHINA AND TRADITIONAL CHINESE MEDICINE 116, 119 (Guenter
B. Risse ed., 1973). Barefoot doctors are "chosen from among the peasants, still working and being paid as
if peasants, but handling basic medical and health work." Id. Responding to the Communist leaders
attempts to bring health care to millions of rural citizens the state sponsored basic education of these
individuals. Id.
2' Id. at 116.
?4 Id. at 116.
2 See Paul Pickowicz, Barefoot Doctors in China: People, Politics & Paramedicine, in MODERN
CHINA AND TRADITIONAL CHINESE MEDICINE 124 (Guenter B. Risse ed., 1973); Samuel Rosen, Health
Care in Modem China; an Eyewitness, in MODERN CHINA AND TRADITIONAL CHINESE MEDICINE, at 150;
and Wang Xueshao, The Integration of Traditional Medicine in Primary Health Care in Yantai, in WORLD
HEALTH ORGANIZATION REGIONAL OFFICE rOR WESTERN PACIFIC REPORT WORKING GROUP ON THE
INTEGRATION OFTRADITIONAL MEDICINE IN PRIMARY HEALTHCARE 35 (Oct. 3-7, 1983).
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accounts the training included only a short period of classroom study (up to
three months), followed by ongoing hands-on training.26
More interesting, however, is the extensive training barefoot doctors
received in TCM. The Instruction Manual for Barefoot Doctors, by the
Revolutionary Committee of Chiang-chen commune hospital, included over
131 pages on Chinese herbal medicine, as well as thirty pages on
acupuncture. 17 The chapters on TCM were the longest in the manual and
included instruction on over 207 herbal remedies, as well as drawings, to aid
the doctors in recognizing and preparing herbs for medical use.28 By 1983
Chinese doctors reported that over 40% of barefoot doctors' training hours
were in TCM.29
TCM's popularity spread and by 1968 several urban hospitals were
cultivating their own herbal gardens.30  Patients began actively choosing
31traditional treatments over Western therapy. Acupuncture, herbal
remedies, and traditional forms of massage both supplemented and
supplanted modem medicine. 32  Urban hospitals began integrating TCM
beds. 33 By 1983, 6% of hospital beds were occupied by patients undergoing
in TCM treatments. 34
III. THE INTERNATIONAL MOVEMENT
The popularity of TCM abroad became noticeable in the 1960s. 35
Possibly motivated by the general popularity of holistic healing in the United
States and Europe at this time, TCM gained an international following.
Notably in the United States, the United Kingdom, and Australia,
acupuncture and herbal remedies became commonplace.36 As awareness of
2 Pickowicz, supra note 25, at 124.
27 Id. at 142.
id.
29 Xueshao, supra note 25, at 36.
30 Samuel Rosen, Health Care in Modern China; an Eyewitness, in MODERN CHINA AND
TRADrTONAL CHINESE MEDICINE 150 (Guenter B. Risse ed., 1973).
31 Levin, supra note 22, at 108.
32 Tian Jingfu, The Role and Position of Traditional Chinese Medicine in Primary Health Care,
WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR WESTERN PACIFIC REPORT, supra note 25, at 31.
33 id.
3 Xueshao, supra, note 29, at 35.
35 Mike Mitka, Alternative Medicine No Fad, 286 JAMA 1443 (2001), at http://jama.ama-
assn.org/issues/v286n 12/fpdf/jqu 10008.pdf.
36 See AMA Report 12 of the Council on Scientific Affairs (A-97) Alternative Medicine, AMERICAN
MEDICAL ASSOCIATION, at http://www.ama-assn.orglamalpub/article/2036-2523.html May 9, 2002. See
also ALAN BENSOUSSAN & DR. STEPHEN MYERS, VICTORIAN DEPT. OF HUMAN SERVICES, TOWARDS A
SAFER CHOICE: THE PRACTICE OF TRADITIONAL CHINESE MEDICINE IN AUSTRALIA, at
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TCM among foreigners grew, the China Academy of Traditional Chinese
Medicine received more attention from international researchers and
Chinese scientists. 37 Investigation of TCM treatments resulted in scientific
indicators, which are widely interpreted as proof, of medical benefits from
TCM therapy. Controlled, scientific studies became more common.
38
In 1983, the World Health Organization ("WHO") held a conference
in the Philippines on integrating traditional medicine into primary
healthcare. 39 The conference featured several Chinese TCM scholars. 40  A
similar WHO conference occurred in Guangzhou in October of 1985 to aid
the education of the international community.4' In 1991, representatives
from over forty countries attended, and governmental officers from twenty
countries participated in an international conference in Beijing. 42  These
large conferences, with high-ranking international delegations in attendance,
indicated the status gained by TCM in the international community.
Skyrocketing healthcare costs, longer life expectancy, perceived failure of
Western trained doctors to practice preventive medicine, lack of effective
communication with patients, and new diseases all contributed to the
international community's motivation to search for alternative, preferably
cheaper medical treatments.4 3
http://dhs.vic.gov.aulphblhceChinesebooklet/title.htm (last visited Jan. 30, 2002) (see Executive
Summary).
37 Since 1955, the Academy has received thirteen Albert Einstein Work Awards of Science from the
World Cultural Council, http://china-window.comlzhonggamy/e._zyyjy.html (last visited Oct. 8, 2001).
The Albert Einstein World Award of Science is the highest recognition granted to a scientist for his
outstanding labor in benefit of science and mankind by the World Cultural Council. See The World
Cultural Council, Albert Einstein Award of Science, http://www.umanitoba.ca/academic-supportt
research_adminlors/funding/pages/index_uz/rzl46c.htm (last visited Apr. 14, 2002). An interdisciplinary
Committee of 120 world-renowned scientists (among them twenty-five winners of the Nobel prize) elect
the recipient of the award. Id. The award covers fields such as: environmental protection, energy use,
human nutrition and increasing natural food reserves, and is awarded annually. Id. The award consists of
diploma, medal and $10,000. Id.
38 See BENSOUSSAN & MYERS, supra note 36; and Abrams & Steinberg, supra note 2.
39 WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR WESTERN PACIFIC REPORT, supra note 25.
40 id.
41 STATE ADMINISTRATION OF TRADITIONAL CHINESE MEDICINE, PEOPLES' REPUBLIC OF CHINA,
INTERNATIONAL EXCHANGE AND COOPERATION, http://www.satcm.gov.cn/English-satcmguojijiaoliu.htm
(last visited Mar. 26, 2002) [hereinafter SATCM].
42 Id.
43 See AMA Report 12 of the Council on Scientific Affairs (A-97) Alternative Medicine, supra note 36
and M. J. Friedrich, Chinese and US Health Care Leaders Discuss Challenges of the 21" Century, 286
JAMA 659 (2001).
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A. Global Market Pressures
The international community continues to debate the benefits of TCM.
There is apprehension regarding the standardization of TCM products,
practitioners and treatment. New Chinese regulations regarding product
quality, licensing, foreign investment, and regulatory enforcement all affect
the international TCM climate.
1. The United States
Despite questionable benefits and quality control procedures, the use
of alternative medicine in the United States continues to expand.
Expenditures on herbal remedies have doubled in the United States since
1985 and now total $1.13 billion annually. 44 In a national survey, one-third
of Americans claimed use of an alternative therapy (not necessarily TCM) in
1996, and total annual alternative medicine expenditures in 1996 were
estimated at $13.7 billion.45 This expenditure exceeded the cost of hospital
46
care in the United States in 1990 (estimated at $12.8 billion). Moreover,
U.S. physicians are displaying greater interest in alternative therapies. A
national study determined 94% of family physicians were willing to refer
patients to at least one form of alternative therapy.
4 7
The United States lacks national regulation on the practice of TCM.
However, several U.S. states regulate the practice of TCM; some have even
created their own exams to test practitioners applying for licenses.
4 8
However, most of this regulation is aimed solely at acupuncture and ignores
growing segments of the population utilizing Chinese herbal remedies.
4 9
Lack of independent testing, research, and labeling of herbal
supplements in the United States allows for false or misleading advertising
44 AMA Report 12 of the Council on Scientific Affairs (A-97), supra note 36:
45 id.
4 id.
47 Id.
48 Currently Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia,
Florida, Hawaii, Illinois, Iowa, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Missouri,
Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oregon,
Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Virginia, Washington, West Virginia,
and Wisconsin have regulatory legislation in place. Medboo, TCM Distance Training FAQ,
http://medboo.con/eng/training/faq.htm (last visited Mar 26, 2002). Eleven other states have introduced
legislation to regulate various types of TCM. Id.
49 BENSOUSSAN & MYERS, supra note 36.
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as well as potentially dangerous directions for use.50 Herbal supplements in
the United States may not be advertised as "cures" or "drugs," and herbal
remedies do not face the intense scrutiny of the U.S. Food and Drug
Administration ("FDA").51 Instead, Chinese medicines are regulated as
herbal' supplements by the Dietary Supplements Health Education Act
("DSHEA").52 Passed 1994, this act responded to popular outcry for the
allowance of a class for herbal remedies separate from food and drugs.
53
U.S. citizens desired immediate and uncomplicated access to herbal
remedies, something that would not be available if herbal supplements were
subject to FDA regulation. DSHEA calls for only minimal standards in
labeling and advertising and requires no specific approval to make claims.
54
Instead, the supplements packages must contain a simple disclaimer: "This
statement has not been evaluated by the FDA. This product is not intended
to diagnose, treat, cure or prevent disease." 55 Despite the lack of research or
seals of approval by government agencies, use of herbal remedies continues
to increase dramatically in the United States. 56 Arguably, China's recently
updated pharmaceutical laws,57 which include regulation of Chinese herbal
medicines, are better equipped than U.S. domestic laws to ensure the quality
58
of herbal remedies. DSHEA limits regulation to control over labeling
claims, and in certain circumstances may prescribe "good manufacturing
'0 For a discussion on continuing concerns with supplement labeling, see Dietary Supplements,
Comments on the Report of the Commission of Dietary Supplement Labels, 63 Fed. Reg. 23633 (Apr. 29,
1998).
5t Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 13, 108 Stat. 4334
(codified as amended at 42 U.S.C. § 485C (c) (2)).
52 id.
53 Over one million letters were sent to Congress in support of DSHEA. Rooted in Folk Medicine,
Many of These -Botanical Anti-diabetic Agents are Used Successfully for Diabetes Control,
http://www.alternativediabetes.com (last visited Apr. 14, 2002).
54 Id.
55 BENSOUSSAN & MYERS, supra note 36. See also Adapted from National Center for
Complementary & Rooted in Folk Medicine, Many of These Botanical Anti-diabetic Agents are Used
Successfully for Diabetes Control, supra note 53.
56 David M. Eisenberg et al., Unconventional Medicine in the United States, 328 NEw ENGLAND
JOURNAL OF MEDICINE 246 (1993); David M. Eisenberg et al., Trends in Alternative Medicine Use in the
United States, 1990-1997, Results of a Follow-Up National Survey, 280 (18) JAMA 1569 (1998), available
at http://jama.ama-assn.org/issues/v280nl8/ abs/joc80870.html (last visited Apr. 08, 2002); and 4 of 10
People Use Alternative Medicine in the United States, SCIENCE NEWS UPDATE, Nov. 11, 1998, available at
http://www.ama-assn.org/sci-pubs/sci-news/1998/snrl 111 .htm
57 See State Drug Administration, New Pharmaceuticals Examination and Approval Procedures
(Apr. 22, 1999) [hereinafter New Pharmaceuticals Examination and Approval Procedures] and PRC
Administration of Pharmaceuticals Law (Revised) (Adopted 7' Session of the Standing Committee of the
5' National People's Congress, Sept. 20, 1984, last amended by the 20"' Session of the Standing
Committee of the 9"' National People's Congress Feb. 28, 2001) [hereinafter Administration of
Pharmaceuticals Law (Revised)].
s8 See infra Part IV.B (discussing Chinese law regarding TCM definition, regulation, and testing).
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guidelines." 59 Conversely, Chinese pharmaceutical regulations specifically
apply to TCM products and require testing, clinical trials and extensive
informational labeling.
60
Perhaps in response to the perceived leniency of U.S. regulations, or
perhaps in response to the growing concerns voiced by the citizens, the U.S.
federal government created the Office of Alternative Medicine ("OAM") in
1995.6 1 This office evaluates a variety of alternative treatments and provides
support for research training. 62 The initial annual budget of the OAM was
$2 million dollars, while in 1997 the budget was approved at $11.1 million.
63
However, the office does not directly support training in alternative
medicine via fellowships or scholarships, as the federal government does for
other medical training programs. The OAM is primarily concerned with the
investigation and dissemination of information on TCM.
The role the United States government will take in regulation of TCM
is still unclear. Despite the gap in federal regulation of quality, the U.S.
federal government recognizes the increased popularity and touted benefits
of alternative medicine. Responding to millions of Americans dependent
upon social security, Congress amended the Social Security Act in
conjunction with the establishment of the OAM, and now provides Medicare
coverage for qualified acupuncturist's services not exceeding 65% of the
scheduled fee for a service provided by a physician. 64 In addition, insurance
companies in the United States have begun to cover the costs of TCM
treatments.65  This coverage, and the ongoing debate on the viability of
TCM, affects all segments of the U.S. population.
66
2. Australia
Unlike the United States, Australia regulates acupuncture and herbal
remedies under existing general laws. Australian laws on skin penetration
59 DSHEA regulates "herbal and other botanical substances" presumably including herbal TCM
products. See Dietary Supplement Health and Education Act of 1994 supra note 51, §§ 3 (a), 9.
60 See infra Part IV.B.3. (describing recent pharmaceutical laws and quality control procedures in
China). Generally relevant Chinese pharmaceutical law is contained in New Pharmaceuticals Examination
and Approval Procedures, supra note 57, and Administration of Pharmaceuticals Law (Revised), supra
note 57.
6' BENSOUSSAN & MYERS, supra note 36.
62 id.
63 AMA Report 12 of the Council on Scientific Affairs (A-97), supra note 44.
64 BENSOUSSAN & MYERS, supra note 36.
65 Kathleen M. Boozang, Is the Alternative Medicine? Managed Care Apparently Thinks So, 32
CoNN. L. REv. 567, 575 (2000).
6 For a good analysis, see Boozang, supra note 65. See also Kathleen Boozang, Western Medicine
Opens the Door to Alternative Medicine, 24 AM. J. L. AND MED. 185 (1998).
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and use of medical implements are interpreted to include acupuncture. 7
Herbal remedies are regulated as therapeutic goods or medical substances.
6 8
These regulations, while not specifically directed at TCM products, are
nonetheless effective, ensuring most TCM products meet the general
standards for medicines within the country. In addition, Australia recently
created a commission to draft legislation on the training and practice of
TCM in Australia, including specific clauses regulating Chinese
practitioners and other long-time practitioners currently working in
alternative medicine fields.
69
3. Europe
In contrast to the United States, European nations generally allow
traditional products to claim actual medical benefits based upon known
traditional uses. 70  In the case of Germany, the products' actual
manufacturing process is regulated to ensure potency.71 The German
Federal Health Agency is a special commission working to approve TCM
products. 72  The efficacy information used in the approval process is
supplemented by case reports, historical data, and data from other scientific
literature.73  Similarly, the United Kingdom allows approval based upon
prior use.74 Arguably, this regulation provides as target for the new national
Chinese regulations.
B. China and the International Market
The growth in demand for TCM did not create corresponding
economic benefits in China. While TCM has been encouraged since 1955,
and its development was specifically promoted in the 1982 PRC
Constitution,75 little direct and enforceable legislation oversaw TCM
67 BENSOUSSAN & MYERS, supra note 36.
68 Id.
69 id.
70 Workshop on Alternative Medicine, Alternative Medicine: Expanding Medical Horizons: A
Report to the National Institutes of Health on Alternative Medical Systems and Practices in the United
States (1992), http://www.naturalhealthvillage.comreportsrpt2oam/toc.htm.
71 id.
72 AMA Report 12 of the Council n Scientific Affairs (A-97), supra note 44.
73 Id.
74 The rule of prior use is "hundreds of years of use with apparent positive effects and no evidence of
detrimental side effects are enough evidence-in lieu of other scientific data that the product is safe."
Workshop on Alternative Medicine, supra note 70.
75 'The state develops medical and health services, promotes modern medicine and traditional
Chinese medicine, encourages and supports .... " XLANFA supra note 6, art. 21.
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development. Irregular application of TCM has resulted in wary
international consumers. China is the world's largest trader of medicinal
plants, the raw materials for herbal TCM.76 These raw exports account for
65% of China's contribution to the global TCM market. However, Chinese
finished products account for only 2% of the international TCM drug
market.7 7 International consumers turn to Japan and Korea for TCM
products, arguably due to the lack of standardization and quality control in
China.
78
In addition to concerns about the quality of Chinese manufacturing,
foreigners worry about the preparation and prescription of Chinese products.
Many TCM medicines available directly from China are essentially raw
materials that must be boiled by the patient to achieve a usable medicine.
79
In countries where tablets, mists, injections or some other form of
standardized dosage is prescribed, it is unlikely that the existing
pharmaceutical systems can accommodate raw materials that must be
prepared by the patient.8 0 This type of treatment also makes it difficult to
determine exact dosages, because the potency of raw materials varies. In
addition, Western doctors and pharmacists regularly deal in uniform, tested
medicines. Western pharmacies have difficulty accommodating alternative
raw products. The most popular alternative products in Western nations are
those actually manufactured outside of China, neatly packaged in capsules or
as teas.81 Regardless of the actual accuracy of these easily administered
dosages, the uniformity and appearance inspire confidence, and users
continue to increase globally.
8 2
Beyond simple regulation of incoming herbal products and TCM
procedures, communities increased their demand for local TCM
practitioners. Escalating numbers of international medical students are
studying TCM in China or via correspondence courses with Chinese
professors. 83 The first program accepting international acupuncture students
76 China Becomes World's Largest Medicinal Plant Trader, XINHUA, Oct. 29, 2001,
http://www.china.org.cn.
77 Zeng Min, Tech Remedy Prescribed for TCM Sector, CHINA DAILY HONG KONG EDmoN, Jun. 4,
2001, http://www1.chinadaily.com.cn/hkindex.html.
78 Id.
79 Chinese Medicine Gets a Booster, CHINA DAILY, Sept. 25, 2001, http:/www.chinadaily.com.cn.
s Id.
81 Dagmar Ehling, Oriental Medicine: An Introduction, 7 ALTERNATIVE THERAPIES no. 4, 71 n. 81
(2001). See also Lisa Corbin Winslow & David J. Kroll, Herbs as Medicines, 158 ARCHIVES OF INTERNAL
MEDICINE 2192, 2194 (1998).
82 "[T]he global herbal medicine market is growing by 10% annually." Let Traditional Medicine
Benefit All, supra note 7.
3 Medboo, supra note 48. See also SATCM, Scientific Research, available at
http://www.satcm.gov.cn (visited Nov. 9, 2001), Medboo Health, Training Center of China Academy of
PACIFIC RIM LAW & POLICY JOURNAL
opened in 1992 at Shanghai Hospital with twenty students; today, 100
international students are in training there.84  Other students have entered
programs sponsored by the Ministry of Foreign Trade and Economic
Cooperation85 or the Medical College of International Studies for Chinese
Medicine in Tianjin.86  The first joint study program was created in 1997
87between Middlesex University and Beijing University. This program is a
five-year, full-time Bachelor of Science program studying TCM.
International demand for holistic healing continues to grow. More
than 120 countries and regions have established schools, programs, and
hospitals utilizing TCM.88 Increasingly, medical professionals recognize
and recommend the benefits of TCM.
IV. THE CHINESE RESPONSE
The global market for TCM is growing by approximately 10%
annually, while the domestic Chinese market is growing at a rate of almost
20% annually. 89 This growth arouses the interest of both international and
domestic businesspeople. However, the lack of technology and enforceable
standards limit China's market share.90 Currently, native Chinese have
patented 5,000 TCM drugs that are produced in China, while foreigners have
patented 10,000 TCM drugs in China for both domestic and international
manufacturing. 91 China primarily supplies the raw materials for these
foreign drugs, but production occurs elsewhere.92 The completed medicines
are then sold back to China as "advanced finished products." 93 As a result,
the country responsible for the development of TCM is unable to compete in
its own market.
Traditional Chinese Medicine available at http://www.medboo.com/eng/catcm.htm (last visited Mar. 26,
2002). See also SATCM, supra note 41.
8 Needle Medicine Attracts Foreign Students, at http://www.eastday.com.cn, Dec. 12, 2000; English
translation available at http://www.china.org.cn.
85 Medical Training Course Attract Foreigners, PEOPLE'S DAILY, Aug. 13, 2001, available at
http://english.peoplesdaily.com.cn.
86 Traditional Medicine Draws West PEOPLE'S DAILY, Nov. 28, 2000, available at
http://english.peoplesdaily.com.cn.
87 Henry Lee, The First Chinese Medicine Degree Programme Outside China, at
http://www.positivehealth.con/permit/Articles/Chinese%2OMedicine/lee32.htm (last visited March 26th,
2002).
88 Let Traditional Medicine Benefit All, supra note 7.
89 Id. See also Zeng, supra note 77.
90 Chinese Medicine Goes Global, May 17, 2001, http://www.english.eastday.com.cn. See also
Nobel Laureate Calls for Modernization of Medicine, supra note 8.
91 Let Traditional Medicine Benefit All, supra note 7.
92 Zeng, supra note 77.
93 Id.
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A. Development of TCM Industry in China
1. Private Investment
Both international and domestic investors are attempting to profit
from ancient Chinese medical knowledge. While there are currently over
1000 TCM companies in China, less than 20% of them could be considered
large or mid-sized companies capable of effectively competing with foreign
pharmaceutical companies. 94  In 2001, leading Chinese distributors,
manufacturers, and innovators created the China Medical Materials Group.95
This conglomerate intends to invest in research and development as well as
new high-tech methods of production for TCM.96 In addition, venture
capitalists invested $12 million in a three-year program run by the Shanghai
Biotechnology and Pharmaceutical Industry Office. 97 Similar programs at
the Shanghai Innovation Centre, the TCM Standardization Research Centre,
and the National TCM Pharmaceutical Engineering and Technology Centre
race toward the same goal: the creation of high-tech methods of mass
production of standardized herbal medications in the form of easily taken
tablets, sprays, and injections. 98 These organizations expect sales to increase
by $12 million within the next year.99 These developments are aimed at the
foreign consumer, who is concerned with neat, consistent packing, and
standardized dosage.
Private enterprise in China is severely limited by the international
community's perception that the medications manufactured are of low
quality. 1°° The lack of standardization in medicinal quality led Nobel
laureate Ning Yang to call for a modernization of TCM production at an
international symposium held in October 2001.101 In response to the
international call for standardization, a flurry of attention has focused on a
new technology, chromatographic fingerprint analysis. 102
94 Zeng Min, Traditional Medicine Gets Tonic, CHINA DAILY, May 21, 2001, at 2.
95 Id.
96 id.
97 Chinese Medicine Gets a Booster, supra note 79.
9& Id. See also China to Have its Largest "'Medicine Valley," (Dec. 19, 2001),
http://www.china.org.cn.
99 Chinese Medicine Gets a Booster, supra note 79.
'00 Nobel Laureate Calls for Modernization of Medicine, supra note 8.
lot Id.
112 China to Use Fingerprint Technique to Control Quality of Traditional Chinese Medicine, XINHUA,
Nov. 10, 2001, available at httpJ/wwwl.chinadaily.com.cn/news/cn/2001-10-23/40102.html.
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Chromatographic technology can be used to analyze both medicinal
crops and finished TCM medicines. 03 The technology compares the TCM
crop or medicine to a standard specimen and determines the quality and
ingredients, and hence the potency of a particular dosage. Unlike
spectrophotometric technology, used to examine and determine the potency
of the active ingredients of most Western drugs, chromatographic analysis
allows evaluation of the potency of multi-component medicines. 0 5 The
State Drug Administration has already announced its intent to utilize
chromatographic fingerprint analysis for its new quality assessment
programs.
Questions remain as to whether this new process, virtually unknown
in the West, will be accepted by the world market. While both domestic and
foreign consumers will benefit from better quality control, private
investment will be easier to obtain for a globally accepted production
process. If chromatographic analysis is primarily a tool to benefit Chinese
consumers, the Chinese national government will stand virtually alone as
principal advocate of the process.
2. Government Investment
The Chinese have made the development of TCM a priority since
1982.107 Stiffer regulations and increased educational opportunities received
further attention when the industrialization of high-tech TCM development
was made a key task in the Chinese tenth Five Year Plan (2001-2005). 108
Furthermore, municipalities and local governments have made direct
monetary investments in the modernization of TCM.I°9 Largely due to fears
concerning the growth of foreign pharmaceuticals companies, the municipal
governments set aside money for basic research and development, as well as
modem techniques, to make the discoveries economically viable in the
fiercely competitive global market." 0 The results can be impressive: one
corporation's TCM sales increased by one-quarter in a single year."
103 id.
104 Id.
105 id.
106 Id.
107 See XIANFA, supra note 6, art. 21 (1982).
108 Zhang Feng, Traditional Medicine Fostered, CHINA DAILY, Feb. 21, 2001, at 2.
09 Chinese Medicine Gets a Booster, supra note 79. See also Zeng, supra note 94.
10 In 2001-2002 Shanghai municipal government alone set aside $14.5 million for basic TCM
research. Chinese Medicine Gets a Booster, supra note 79.
111 Chinese Medicine Goes Global, supra note 90.
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Most of the state sponsored TCM research and development occurs
within state institutions, most notably the Beijing University of Chinese
Medicine. By 1995 there were 100 TCM scientific research organizations
based in these institutions and over 20,000 part-time scientific researchers
with college educations. 12 In addition, recent research has focused on the
creation of synthetic materials as substitutes for traditional ingredients
extracted from endangered species. 113 This research has been successful and
state institutions no longer use endangered species in research.'
14
The government invests not only in actual research, development, and
production, but also in increasing Chinese visibility in the TCM arena. The
nation's top advisory body suggested and is currently constructing a national
TCM museum that will "collect, preserve and exhibit the traditional medical
heritage of China's various groups."' 15 The Chinese focus on TCM in recent
years displays a mounting recognition of TCM as a national treasure,
intended to benefit Chinese citizens as well as satisfying international
demand. Various municipalities house international symposiums,
conventions, and even festivals to honor and investigate Chinese
medicine." 6 These international events emphasize China's determination to
enter the global TCM market as a member of the international community.
Moreover, the sharing of ideas and information solidifies China's image as a
quality care provider.
China actively fosters its relationship with the World Health
Organization. For example, China issued a statement exhibiting great pride
when the WHO officially proposed acupuncture therapy for forty-three
diseases." 7 Perhaps more interestingly, China actively seeks cooperative
relationships with other countries. Governmental exchange has occurred in
response to ravenous diseases such as AIDS and cancer. 118 TCM remedies
112 SATCM, Scientific Research, State Administration of Traditional Chinese Medicine People's
Republic of China, http://www.satcm.gov.cn/englishsatcm/keyan.htm (last visited May, 14 2002).
"' Amy E. Vulpio, From the Forests of Asia to the Pharmacies of New York City: Searching for a
Safe Haven for Rhinos and Tigers, 11 Geo. Int'l Envtl. L. Rev. 463,482-83 (Winter 1999).
114 Endangered Species Well Protected, CHINA DAILY, Apr. 3, 2001, available at
http://www.chinadaily.com.cn. For a more complete discussion of the trade of endangered species for use
in TCM, see William Carroll Muffett, Regulating the Trade in Bear Parts for Use in Asian Traditional
Medicine, 80 Minn. L. Rev. 1283 (May 1996). See also Vulpio, supra note 113.
15 China to Build a Museum of Traditional Herbal Medicine, XINHAU, Nov. 8, 2001, available at
http://www.china.org.cn.
116 The second China International Health-Care Festival sponsored by the Yunnan Provincial
government housed 400 enterprises from the United States, Canada, Japan, China and various other
countries to focus on the development of TCM products and technology. Health-Care Festival Highlights
Traditional Chinese Medicine, XINHUA NEWS AGENCY, Nov. 21, 2001, available at www.china.org.cn.
"7 SATCM, supra note 41
H See Abrams & Steinberg, supra note 2.
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offer some relief of symptoms, and via government cooperation, China
exports herbal medicines to 130 countries.'19
B. Regulation of TCM Industry in China
1. State Administration of TCM
The Chinese government's Ministry of Public Health oversees a
growing organization, the State Administration of Traditional Chinese
Medicine ("SATCM"), dedicated solely to TCM. This organization's duties
are:
formulating guidelines, policies, law, and regulation of TCMP
[Traditional Chinese Medicine and Pharmacology], working out
department rules and regulations and supervising their
implementation; formulating and organizing the
implementation of the development strategies of TCMP,
drawing up intermediate and long-term developing projects and
annual programs; supervising appropriation of special funds
and loans and emergency allocation of TCMP resources in
cases of disasters, pestilence and for military requirements;
guiding the therapy, nursing, rehabilitation and health care of
traditional Chinese medicine, integration of traditional Chinese
medicine and Western medicine and national medicine;
supervising the production and trade of the Chinese medicines;
organizing personnel training, scientific research, technological
development and protection of intellectual property; developing
international scientific exchange and cooperation; and making
plans on export and import of Chinese medicines.
120
This organization, in conjunction with several regional and municipal
governments, has promulgated 170 pieces of TCM legislation since 1982.121
19 SATCM, supra note 41.
120 State Administration of Traditional Chinese Medicine. at http://www.cintcm.ac.cn/gam
e_index6.html (note original translation slightly modified for readability) (last visited March 26th, 2002).
121 See, e.g., Law on Drug Management 1985; Law on Certified Physicians 1998; Regulations on the
Protection of Wild Medicinal Resource; Regulations on the Protection of TCVM Drug Varieties;
Regulations on the Management of Medical Institutions; The Regulation of Anhui Province on the
Development of Traditional Chinese Medicine (July 28, 2001); The Regulation of Beijing Municipality on
the Development of Traditional Chinese Medicine (June 22, 2001); The Notice of the Ministry of Health
Concerning Restriction the Production of Health Foods Using Licorice Root; Chinese Ehedra; Desert
Cistanche; Snow Lotus and Their Product in Raw Materials (June 1, 2001); The Regulations of Shanzi
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This legislation is primarily concerned with the domestic development,
production, and sale of TCM.
National regulation of TCM accelerated in 1992 with the Regulations
122on Protection of Traditional Chinese Medicines, effective January 1, 1993.
This regulation aims to raise the quality of all varieties of traditional Chinese
medicines, promote the development of TCM medicines, and perhaps most
importantly, protect the legal rights and interests of enterprises engaging in
the production of TCM.123  Formerly, businesses could patent specific
medical compounds, including TCM compounds.124  Unfortunately, due to
undeveloped intellectual property laws and the general lack of awareness
regarding intellectual property rights, few TCM providers patented their
products. 125  It is estimated that foreigners currently own 70% of the
intellectual property rights in herbal medicine globally.
126
The Regulations on Protection of Traditional Chinese Medicines
protect all TCM products127 prepared or produced in China with minimal
filing hassle and extended periods of protection, including secrecy.
128
Unlike the U.S. patent system which discloses all patent application
material, 129 TCM products applying for protection under the Regulations on
Protection of Traditional Chinese Medicine are guaranteed complete
secrecy, by both the applicant and the government bodies possessing the
application materials, for a minimum of seven and up to thirty years,1
3°
Province on the Development of Traditional Chinese Medicine (May 21, 2001); The Measures of Tianjin
Municipality for Administration of Chinese Traditional Medicine Pieces for Decoration (Apr. 30, 2001);
The Regulations of the Inner Mongolia Autonomous Region on Traditional Mongolian Medicine and
Traditional Chinese Medicine (Feb. 12, 2001); The Regulations of Gansuu Province on Developing
Traditional Chinese Medicine (Nov. 27, 2000 & Dec. 2, 2000); The Regulations of Jiangxi Province on the
Development of Traditional Chinese Medicine (June 27, 2000) (www.chinalegalchange.com ); Circular of
State Administration of Chinese Traditional Medicine Ministry of Foreign Trade and Economic
Cooperation State Administration of Import and Export Commodity Inspection and Customs General A
administration on Implementing the Quality Registration; Inspection and Releasing System of Chinese
Traditional Medicines to be Exported.
122 Regulation on Protection of Traditional Chinese Medicine, supra note 1.
123 Id. at art. I.
124 The Regulations on Protection of Traditional Chinese Medicines specifically precludes individuals
otherwise applying for patent rights under 'the law governing patent rights' from applying for protection
under the Regulations on Protection of Traditional Chinese Medicines. Regulation on Protection of
Traditional Chinese Medicine, supra note 1.
t2 Experts Call for Protection of Traditional Chinese Medicine, CHINA DAILY, Nov. 25, 2001,
available at http://www.chinadaily.com.cn.
126 Id.
127 TCM products are defined as "traditional Chinese proprietary medicines, the extract and
preparation of medicinal herbs and processed traditional Chinese herbs." Regulations on the Protection of
Traditional Chinese Medicines, supra note 1, chap. 1 art. 2.
128 Regulation on Protection of Traditional Chinese Medicine, supra note 1.
129 35 U.S.C.S § 112.
130 Regulation on Protection of Traditional Chinese Medicine, supra note 1.
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depending upon the grade assigned to the medicine. 131 Moreover, this
period of protection and secrecy may be extended upon request, provided the
extended period does not exceed the initial period of protection.132 For
example, if the applicant was initially awarded thirty years of protection, the
extension can be an additional thirty years (for a total of sixty years
protection), but nothing greater.
Special departments under the State Council work in conjunction with
experts of traditional Chinese medicine in areas of clinical and scientific
research, laboratory experimentation, administration and management to
determine the viability of an application.' 33 Once a medication is approved
for protection, the applicant is issued a "Certificate of Variety of Traditional
Chinese Medicine under Protection" that protects the rights of the
applicant.
134
The law does provide an exception for medications found to be "much
in need of clinically."' 135  While the terminology is undefined by the
regulation, presumably "much in need of clinically" refers to an epidemic
that the local, municipal, or national government feels compelled to curtail.
Utilizing this provision, the national government may allow health
departments in a municipality, region, or province to replicate the
medication. However, the national government is responsible for giving
reasonable compensation to the applicant for the loss of the protected
medical variety. Unfortunately, Chinese government's historic idea of
compensation has differed greatly from both domestic and international
patent holders. There are also continuing concerns with the general lack of
respect in China for intellectual property rights. 137 Lack of definitions seems
to maintain a legal loophole ripe for government abuse. However, the law
strictly punishes applicants who fail to abide by its provisions.
38
Violation of the Regulation on Protection of Traditional Chinese
Medicine may result in fines, removal of the certificate of authority,
confiscation of fraudulent products, and criminal sanctions. 139 This strict
punishment structure indicates a desire to strongly discourage any violation.
31 lart. VI & XII.
3 See id., art. XV & XVI.
133 Id., chap. II art. 5.
.4 Id, chap II Art. 9.
I" Id., art. XIX.
136 Id.
137 See Experts Call for Protection of Traditional Chinese Medicine, supra note 125.
133 Regulation on Protection of Traditional Chinese Medicine, supra note 1, art. XXII-XXIV.
139 See Administration of Pharmaceuticals Law (Revised), supra note 57.
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Despite the strong wording of this regulation, the success of actual
enforcement is generally unknown. 140
As with most Chinese legislation, enforcement is problematic without
cooperation by local government officials and bureaucrats. 141 Chinese legal
scholars debate the simple existence of a Chinese legal system.142
Enforcement of national laws occurs only with the support of local officials,
many of whom may have interests conflicting with the new regulation. 143
For example, enforcement of SATCM legislation occurs primarily through
investigation by local authorities. 144 If a local investigation occurs at all,
collection of fines or retrieval of the plant's license would be left to local
government officials. 145 A public official who maintains substantial interests
in a nonconforming TCM manufacturing plant, as a part of the State Owned
(or aided) Enterprise ("SOE"), is unlikely to fine the plant for any violations.
The problem is compounded by increased difficulties with enforcement in
port cities used for international trade. 146 These areas experience greater
marketization than interior cities and are less likely to adhere to government
regulations. 147
Despite problems with local enforcement of national laws, directives
and regulations, international TCM consumers should begin to feel more
140 Some evidence exists that as many as one-half of China's drug producers should be shut down
because they fall below WTO standards or produce pirated products. Although some evidence is available
concerning shutdowns of illegal factories and confiscation of medicines, the investigations are still
considered preliminary. See Financial Times Information, EFE NEWS SERVICE China-WTO-Drugs Low
Standards, Pirated Brands Threaten Chinese Drug Industry Mar. 12, 2002, available at LEXIS, EFE News
Service. See also BBC Summary of World Broadcasts, Law and Order: Hebei Illegal Pharmacy May 7,
1980, available at LEXIS, BBC Summary of World Broadcasts.
141 Donald C. Clarke, What's Law Got to Do with It? Legal Institutions and Economic Reform in
China, 10 U.C.L.A. PAC. BASIN LJ. 1, 30-37 (1991).
142 See THOMAS V. STEVENS, ORDER AND DISCIPLINE IN CHINA 3-12 (1992).
143 See generally XIAOYING MA & LEONARD ORTOLANO, ENVIRONMENTAL REGULATION IN CHINA;
INSTTIONS, ENFORCEMENT, AND COMPLIANCE 15 (Rowman & Littlefield, 2000). See also Clarke, supra
note 141.
1" Circular of State Administration of Chinese Traditional Medicine, Ministry of Foreign Trade and
Economic Cooperation, State Administration of Import and Export Commodity Inspection and Customs
General Administration on Implementing the Quality Registration, Inspection and Releasing of Chinese
Traditional Medicine Apr. 1, 1996. See also Regulation on Protection of Traditional Chinese Medicine,
supra note 1, chap H, art. 9 (1).145 Regulation on Protection of Traditional Chinese Medicine, supra note 1, chap. IV art. 23.
146 For an examination and report of smuggling and corruption in several customs areas and special
economic zones, see Cary Huang and Fong Tak-ho Hundreds Detained in $5b Tax-Scandal Probe, HONG
KONG IMAIL, Sept. 22, 2000, Qin Jie et al, Xinhua Feature on Xiamen Smuggling Case, BEIJING XINHUA
DOMESTIC SERVICE, July 25, 2001. See also Liu Xiaosen and Gai Jindong, China Urges Crackdown on
Coastal, Cross-Territorial Crime, BEIJING XINHUA DOMESTIC SERVICE, Jan. 22, 2000.
147 For a discussion of corrupt party members, military cadres, government officials and law-
enforcement officers aiding in smuggling and customs avoidance, see Cong Yaping, A Heavy Blow to
Smuggling-Commentary on China's Anti-Smuggling Struggle Since the Beginning of This Year, BEUING
XINHUA DOMESTIC SERVICE, Dec. 17, 1998.
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confident in TCM product quality. Since May of 1996, all exported Chinese
traditional medicines and their manufacturing processes have been subjected
to inspection by SATCM designated organizations. 148  Manufacturers in
compliance receive a quality registration certificate. 149  This certificate is
revocable upon the investigative organization finding quality control
problems.'
50
Generally, investigative organizations face many of the corruption
problems noted above, but the ability of SATCM to investigate product
quality using independent organizations should minimize the problems.
155
Moreover, product quality violations are subject to criminal sanctions'
52
The criminal law system receives more positive attention than the civil law
structure. 53 Enforcement of criminal sanctions is more likely to occur than
enforcement of fines or other equitable remedies! 54 However, there is
concern due to the enforcement issues outlined above concerning local
protectionism, as well as a general focus on confession and re-education of
criminal elements, that criminal sanctions may be less likely to be imposed
at all.
155
A finding of substandard product quality domestically or in products
for import results in imposition of Article 140 of the Criminal Law. 156 This
article details the penalties for producers and sellers of products that are
substandard for a variety of reasons. Punishment is based upon the intent
and possible repercussions of using the substandard product.
The investigation of TCM exports brings together the State
Administration of Chinese Traditional Medicine, Ministry of Foreign Trade
and Economic Cooperation, and the State Administration of Import and
141 "As of May 1, 1996, Chinese traditional medicines to be exported and their manufacturing
enterprises shall undergo inspection by quality inspection organizations designated by the State
Administration of Chinese Traditional Medicines." Circular of State Administration of Chinese Traditional
Medicine, Ministry of Foreign Trade and Economic Cooperation, State Administration of Import and
Export Commodity Inspection and Customs General Administration on Implementing the Quality
Registration, Inspection and Releasing of Chinese Traditional Medicine, supra note 144.
"' Regulation on Protection of Traditional Chinese Medicine, supra note 1, chap. II art. 9 (3).
50 Id chap. IV art. 23.
11 Id. chap. II art. 9 (2).
152 National People's Congress, Clarifications on Criminal Liability for Dealing in Counterfeit or
Inferior Goods, Mar. 15, 2001, available at CHINA LEGAL CHANGE, Issue 7, Apr. 18, 2001.
153 Donald C. Clarke, The Execution of Civil Judgments in China, 141 CHINA QUARTERLY 65, 70
(1995).
154 Id. at 153 (general discussion of civil judgment decisions and enforcement).
155 Several individuals and enterprises were treated leniently after voluntary confessions and agreeing
to self-investigation in smuggling cases. See Qin Jie et al., Xinhua Feature on Xiamen Smuggling Case,
BEUING XINHUA DOMESTIC SERVICE, July 25,2001.
156 National People's Congress, supra note 152.
157 Providing a product that could result in serious injury to more than three people can result in a
death sentence. National People's Congress, supra note 152.
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Export Commodity Inspection to issue yearly statements of exportable TCM
and TCM producers.ls s The support of a variety of organizations indicates
that this regulation is more likely to be enforced than other regulations
originating from a single department, council, or ministry. Collaboration
among the branches ensures not only completion of the investigation, but
also of any follow-up measures. As this policy is aimed directly at exported
products, it credits the theory that China's latest TCM regulation is largely a
response to international pressure.
2. Regulations Protecting TCM Quality
The State Drug Administration works in conjunction with these
national and regional TCM laws to create national legislation regulating the
development, production and sale of pharmaceuticals, specifically including
TCM drugs.'- 9 TCM drugs include any "man-made manufactures of
traditional Chinese medicine" and "newly formulated prescription
preparations made from traditional Chinese medicines."' 16° Although the
laws do specify a few areas where TCM drug regulation differs from
conventional drug regulation, as a general rule, TCM drug manufacturers,
distributors, and wholesalers are held to the same standards as other Chinese
drug manufacturers.' 16  Under these new laws, all manufacturers, producers
and wholesalers must be licensed by local and national agencies, all drug
institutions are subject to investigation, and violation of the laws results in
large fines and loss of license.
162
3. New Pharmaceutical Examination and Approval Procedures
China is subjecting TCM medications to more rigorous
pharmaceutical testing. 63 Several recent laws revised the examination and
approval procedures for drugs produced in China. These regulations set out
158 See Circular of State Administration of Chinese Traditional Medicine, Ministry of Foreign Trade
and Economic Cooperation, State Administration of Import and Export Commodity Inspection and
Customs General Administration on Implementing the Quality Registration, Inspection and Releasing of
Chinese Traditional Medicine, supra note 144.
159 See New Pharmaceuticals Examination and Approval Procedures, supra note 57, and
Administration of Pharmaceuticals Law (Revised), supra note 57.
160 New Pharmaceuticals Examination and Approval Procedures, supra note 57.
161 Decoction (extracts obtained by boiling raw materials) TCM products are subject to separate
standards to be issued by the State Council. See Administration of Pharmaceuticals Law (Revised), supra
note 57 at art. 10.
162 Id. art 73-96.
163 See New Pharmaceuticals Examination and Approval Procedures, supra note 57, and
Administration of Pharmaceuticals Law (Revised), supra note 57.
PACIFIC Rim LAW & POLICY JOURNAL VOL. 11 No. 3
discrete steps for application, clinical testing and approval. 164 TCM is
generally considered a Category 1 pharmaceutical 165 and subject to State
pharmaceutical standards. 66 The law specifically notes the additional
requirements for TCM medications including sourcing, cultivation,
ecological environment, collection, handling, processing, and preparation
information included in the pretrial testing phase. 167  Only after final
completion, reporting, and examination may the medicines be approved for
production. 16 This process aims to assure the quality of the product as well
as provide documented scientific backing for the product claims from both a
municipal and national level.1 69
4. Internet Regulation
To limit the ability of Chinese products to reach the international
market without proper investigation and certification, the Chinese
government restricts the sales channels of Chinese TCM suppliers. The
State Drug Administration and the Ministry of Health cooperate to attack
fertile ground for both domestic and international purchase of TCM
medicines: the Internet.' 70  Legislation passed in 2000 and 2001 regulating
online advertising and sales of Chinese medicine.17 1 On January 1, 2000, the
164 Part 3-6 New Pharmaceuticals Examination and Approval Procedures, supra note 57.
'65 Category 1 Pharmaceuticals include "(a) man-made manufactures of traditional Chinese medicinal
materials, raw material medicines manufactured through synthesis or semi-synthesis, and their
preparations, (b) effective monomers extracted from natural materials or extracted through fermentation,
and their preparations, (c) combinations of chemicals for which research reports on their medical use exist
abroad but which have not yet been approved for marketing by another country's drug administration."
New Pharmaceuticals Examination and Approval Procedures, supra note 57, part II, art. 6.
16 Some exception is made for "decoction" TCM products that are subject to separate standards to be
issued by the State Council. New Pharmaceuticals Examination and Approval Procedures, supra note 57,
part 2, art. 6. See also Administration of Pharmaceuticals Law (Revised), supra note 57.
167 The pretrial testing is followed by four stages of clinical trials. New Pharmaceuticals Examination
and Aproval Procedures, supra note 57, part III.
New Pharmaceuticals Examination and Approval Procedures, supra note 57, part 6, art. 44.
169 See New Pharmaceuticals Examination and Approval Procedures, supra note 57, part 1, art. 1.
17o See Ministry of Health, Administration of Internet-based Medical and Health Information Services
Procedures, (Jan. 01, 2001), and State Drug Administration, Administration of Internet-based
Pharmaceutical Information Services Tentative Provisions, (Jan. 11, 2001).
171 See China Economic Information Network, Green Light for Online Medicine Purchases,
Economic News, at http://ce.cei.gov.cnlenew/new-e2/eb2hOj39.htm (Nov. 19, 2000). See also China
Economic Information Network, The Supervision of Medicine Ads to be Strengthened, at
http://ce.cei.gov.cn/enew/new-fl/pgOOfc68htm (Mar. 24, 2001), and China Economic Information Network,
State Drug Board Cracks down on Pharmaceutical Web Sites, Economic News (Dec. 5, 2000), at
http://ce.cei.gov.cnlenew/new-e2/eb2hOl14.htm) [hereinafter State Drug Board Cracks Down on
Pharmaceutical Web Sites].
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Ministry of Health outlawed online diagnosis and treatment services.
72
Websites touting medical information must receive approval from the
appropriate medical and health authorities and display the seal of approval
on the home page. 173  The Ministry of Health also agreed to designate a
special task force to periodically inspect health and medicine websites for
violations. 174  The State Drug Administration independently screens and
regulates providers and traders of online pharmaceutical information. 175 The
concern of both agencies indicates it is receiving support from various
government camps. In the short term, enforcement is likely as Internet
regulation is currently a popular campaign in China. 176  The long-term
enforceability of this law, particularly given the tremendous progress made
in Internet sales, remains questionable.
China hosts a rapidly growing online medicinal market. 177 In contrast
to the expected response to online sales within China, Chinese authorities
are encouraging medicinal websites.178  However, the goal is the creation
and support of truthful, professional websites, preferably correlated with
established, legal pharmaceutical companies. 179 China is greatly concerned
with the potential for false advertising and the repercussions in the
international community. 80 Truthfulness in advertising will create the
image that China is capable and willing to produce quality medical products.
Prolific international online medical traders ensure stiff competition for their
Chinese counterparts. China's regulation indicates that it understands the
ongoing importance of reliable online medical resources. If China ignored
this potential market, its continuing attempts to establish quality medicine
and international markets would be severely hindered by efficient, quick,
and private online providers.
172 Ministry of Health, Administration of Internet-Based Medical and Health Information Services
Procedures (Jan. 01, 2001).
173 id.
174 Ministry of Health, Administration of Internet-based Medical and Health Information Services
Procedures, supra note 172, art. 12.
175 State Drug Administration, Administration of Internet-based Pharmaceutical Information Services
Tentative Provisions (Jan. 11, 2001).
176 State Drug Administration, The Provisional Regulations concerning Drug Information Service on
the Internet, Decree No. 26 (Jan. 11, 2001). See also State Drug Administration, supra note 175, and
Minist7r of Health, supra note 172.
In 2000, statistics indicated the existence of over 200 pharmaceutical and healthcare websites as
well as forty illegal pharmaceutical websites. See State Drug Board Cracks down on Pharmaceutical Web
Sites, supra note 171.
178 See Green Light for Online Medicine Purchases, supra note 171.
79 id.
1SO See State Drug Administration, The Provisional Regulations Concerning Drug Information
Service on Internet, Decree No. 26, (Jan. 11, 2001), art. 1.
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5. Modern Education and Certification of TCM Professionals
In addition to increasing regulation and standardization of the TCM
drugs, the Chinese government recently issued new legislation regarding the
certification of healthcare professionals.18' Domestic users of both Western
and traditional medicine will benefit from the increased training and uniform
certification of medical professionals. Furthermore, as growing numbers of
international students study in China, the regulations assure the international
community that doctors trained in China are competent.
In 1998, the Ninth People's Congress adopted the Law on Licensed
Doctors of the People's Republic of China.182 This regulation covers both
doctors, and assistant doctors.183 The law requires uniform examinations for
all doctors and assistant doctors formulated by the administrative department
for public health under the State Council. 84 As a prerequisite to taking the
exam, all doctors are required
(i) to graduate from a faculty of medicine of a university and
practice under the guidance of a licensed doctor that works in a
healthcare institution, or
(ii) obtain license as an assistant doctor and graduate from medical
school, and work for two years in medical treatment, or
(iii) graduate from a specialty of medicine at polytechnic school and
work for five years in medical treatment, disease prevention or
healthcare institution.'
85
Assistant doctors are subject to similar requirements, requiring
graduation from a faculty of medicine of a university or polytechnic school
and having worked for at least one year in medical treatment, disease-
prevention or healthcare under the guidance of a licensed doctor.1
i 6
Alternatively, doctors may study TCM for three years via apprenticeship or
field practice, prove mastery of a specialized field, pass TCM exams (exams
are administered by organizations specializing in TCM, disease prevention
or healthcare institution recognized by the Administration for Public Health
at or above the county level), and be recommended by such organization for
1a Law on Licensed Doctors of the People's Republic of China adopted at 3d Meeting of the
Standing Committee of the Ninth National People's Congress (June 26, 1998).
182 Id.
'8 NPC, supra note 181.
:84 Id. at chap. II art. 8.
l Id. at chap. H art. 9 (1-2).
186 Id, at chap. H art. 10.
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license either as a doctor or assistant doctor.' 87 The State Council separately
determines contents of exams under this alternative system.
8 8
Doctors and assistant doctors are also subject to ongoing obligations
to report to the appropriate authorities any problems that occur during the
course of their work, and these problems are subject to state investigation.18
9
However, compliance with this requirement is questionable. Certainly,
malpractice claims in China are seldom successful. 190 As a Chinese
malpractice lawyer stated, "[Y]ou take a chance any time you receive
medical treatment. It's unrealistic to expect a hospital visit to be a complete
risk-free experience."'191 In general, urban Chinese doctors are underpaid
and overworked, seeing fifty to sixty patients in a single day. 92 However,
because of greater regulation at the local level, rural areas theoretically face
fewer problems.193
There are thirty institutions of TCM higher learning in China, three of
which are supervised by SATCM. 194  There are approximately 42,000
students enrolled in the three institutions of higher learning, and 14,000
undergraduates enroll annually. There are 52,000 students studying in the
fifty-one secondary schools and 18,600 enroll annually.1 95  All TCM
education encourages practicable TCM by working in rural areas,
supplemented by continuing education and further specialization. 196 There is
also a strong focus on integration of TCM and Western medicine.
97
Directly resulting from the increased emphasis on TCM and
integration with Western medicine, 22% of outpatients visiting hospitals and
5-10% of hospital patients use TCM departments.198  There are 170,000
TCM professionals working in the cities, and of the 970,000 rural doctors,
almost all utilize TCM. 199 The number of hospitals using TCM quadrupled
187 id.
18 Id.
's9 Id. at chap. III art. 29.
90 Ching-Ching Ni, Maladies of China's Medical System. SEATTLE TMES. Feb. 3, 2002 at A12.
191 Id.
192 id.
93 NPC, supra note 181, at chap. IV art. 31.
194 Twenty colleges of TCM enroll foreign students and twenty-seven offer correspondence courses.
There are five undergraduate TCM specializations, three post-graduate specialties, fifteen second-class
disciplines and fourteen specialties for secondary schools. See State Administration of Traditional Chinese
Medicine People's Republic of China, Education, at http://www.satcm.gov.cn/englishlsatcm/jiaoyu.htm
(last visited Apr. 29, 2002).195 Id.
196 id.
197 id.
'" See The State Administration of Traditional Chinese Medicine of People's Republic of China,
Medical Administration, at http://www.satcm.gov.cni/english/satcm/jiaoyu.htm (last visited Apr. 29, 2002).
199 Id.
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since 1980, and patient costs in TCM hospitals are almost one-quarter less
than the cost of Western-based hospital stays.2°° Domestic benefits of TCM
weigh toward government regulation attempting to capitalize on this national
resource.
C. Effects of TCM Regulation
1. Domestic Improvements
The primary domestic impediment to Chinese entry into the world
market is enforcement of existing laws. Although the Chinese economy
functions without the rigid legal standards of the West, international
consumers desire the guarantees provided by enforceable laws. 20 1 Lack of
enforcement and legal uncertainties impair market transparency. 2 2 Market
transparency is a major issue, particularly in light of the China's accession to
the WTO.2°3  Market transparency generally requires the publication of
relevant legislation, dismantling of economic barriers, and a mode of
administration for "tradeable services. ' 2°4  Lack of enforcement of
administrative actions greatly limits the confidence of foreign investors and
consumers in China.
20 5
The Chinese State Drug Administration found that 6.8% of TCM
medicines and 19.2% of TCM medical materials tested during medicine
inspections were substandard, while 21.4% of TCM medicines used in
206Chinese hospitals were substandard. This investigation of local usage
indicates concern over the risks to domestic users. However, quality control
issues touch upon both the international and national markets for TCM
products. Widespread knowledge of the results of the State Drug
200 Id.
201 This desire is recognized by the Chinese Minister of Foreign Trade and Economic Cooperation
who said a major concern of China post-WTO accession is to "intensify the revisions of policies and
regulation on foreign investment in a step-by-step and planned manner to improve the transparency of
policies and regulations, and further perfect the legal system for foreign investment." Wang Fanfan et al,
Shi Guangsheng Says China to Speed Up Marketization According to WTO Rules, BEIJING XINHIUA HONG
KONG SERVICE IN CHINESE, available at http://wnc.fedworld.gov/cgi-bin/retrieve.cgi (Sept. 8, 2000).
2 "Transparency now requires publication of laws, regulations, and the mode of administration in
tradable services or, to a more limited extent investment regimes." Sylvia Ostry, China and the WTO: The
Transparency Issue, 3 UCLA J. Int'l L. & Foreign Aff. 1, at 9 (1998) (according to this definition, legal
uncertainly due to unpublished law and the lack of enforcement of laws as is the case in much of China
would hinder transparency).
23 Id.
24 Id. at 9.
205 Id.
M6 See Chinatopnews.com, China Cracks Down on Fake Medicine Sales, at
http://www.chinatopnews.comPolitics/MonJan_17_23_39_35_2000.htmil (Jan. 18, 2000).
VOL. I11 No. 3
JuNE 2002 CHINESE REGULATION OF TRADITIONAL CHINESE MEDICINE 713
Administration's investigations could further undercut the international
community's faith in Chinese manufactured medicines. 2° 7 However, some
recent case law from China indicates a willingness to investigate and
prosecute violations of the product guarantee laws.
208
International investments in China are increasing, and relevant
legislation in areas of medicine may become the basis for considerable
profit. 2° 9 However, uncertainty regarding enforcement of both foreign
investment regulation and TCM regulation discourages investment. Nations
of the WTO rely heavily upon transparency to determine trade expectations
and the effectiveness of the legalization of international trade. 21  China's
multi-faceted legal system creates confusion for investors over the existence
and interpretation of applicable law.2 11 Moreover, lack of enforcement of
foreign arbitration awards, as well as the critical estimations of the success
of dispute resolution within the WTO relating to Chinese international trade,
212further inhibits investors. Unfortunately, difficulties with regulatory
enforcement in China, as well as the general disregard for acceptable relief
(particularly for foreigners) indicate that investment and reliance on official
channels remains a dangerous enterprise.
Arguably, any enforcement of TCM law currently is simply a reaction
to the popular propaganda movement advocating TCM as a "Chinese
export." As is commonly the case with Chinese propaganda movements,
213they exist in a single moment in time and are quickly forgotten. Without
assurance of longevity, TCM regulation is nothing more than a passing fad.
The sheer quantity of TCM regulation alone cannot dismiss the real
fear of TCM as a popular, but fast-fading movement. Copious regulation
often indicates a fleeting interest of the Chinese government. However,
TCM regulation has occurred since the 1982 Chinese Constitution made
"7 See EFE News Service File, China-WTO-Drugs Low Standards, Pirated Brands Threaten Chinese
Drug Industry, Mar. 12, 2002, LEXIS. See also EFE News Service and BBC Summary of World
Broadcasts, Law and Order:Hebei Illegal Pharmacy, May 7, 1980, LEXIS.
2M See Pub. Health Bureau of Haungchuan County v. Med. Co. of Huangchuan County, 3 China L.
Rep. 196, 1991 (Intermediate People's Court of Xinyang Prefecture, Oct. 5, 1991).
2o9 MOFTEC, The Statistics About Utilization of Foreign Capital in 2000, available at
http://www.moftec.gov.cn/moftec--entjsj/wazi-Olen.html (last visited April 29,2002).
210 Ostry, supra note 202, at 11.
21 "The problem of securing reliable information has created severe problems for effective resolution
of commercial disputes in China." Id. at. 15 (note also discussion at 13-16 of the multiple tiers of
legislation, interpretation, enforcement and adjudication).
212 Id. at 19.
213 See generally STANLEY LUBMAN, BIRD IN A CAGE: LEGAL REFORM IN CHINA AFTER MAO
(Stanford University Press, 1999) at 133-37 (general discussion of the use and effectiveness of modem
campaigns in China).
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explicit mention of it.214  The Chinese Constitution does not stand as a
formal document of rights and beliefs in the same manner as the U.S.
Constitution,215 but mention of TCM in the document is nonetheless
relevant. Moreover, TCM regulation seems to have only increased since that
time. Arguably, this simply indicates a cresting of the movement; however,
criminalizing aspects of TCM law indicates a real willingness to actively
partake in the regulation of TCM
2. WTO Accession
The Chinese government indicates that it expects the domestic TCM
market to benefit from accession to the WTO. A seminar on April 23, 2000,
216presented by a conglomerate of Chinese government ministries, was
dedicated to examining the effects of WTO membership on TCM.217 The
seminar focused on the influence on Chinese TCM of joining the WTO, as
well as the global market and foreign countries' policies on TCM.218 This
seminar demonstrated the interest of several Chinese government branches
in identifying potential new markets for TCM products resulting from WTO
membership.
However, it is questionable whether WTO membership will create
new markets. China already held Most Favored Nation219 (MFN) status with
most of the primary importers of TCM products prior to its entry into the
WTO. Moreover, China never maintained truly unreasonable tariffs on
traditional medicines.220 It is unlikely the purely political benefits of WTO
214 Id. at 6.
215 'For a general discussion of the function, purpose and scope of the Constitution of the PRC and its
interpretation of personal rights, see William Jones, The Constitution of the People's Republic of China, 63
Wash. U.L.Q 707 (1988), and Andrew Nathan, Chinese Democracy, 111-13 (1986).
216 The Ministry of Health, Ministry of Foreign Economy and Trade, State Administration of
Traditional Chinese Medicine, Pharmaceutical Department of State Economic, and Trade Administration of
Drug Inspection and Supervision of China.
217 See The 7th Branch Meeting of the International Congress on Traditional Medicine, Seminar on
WTO and Development of Traditional Chinese Medicine in the 21' Century, available at
http://www.satcm.gov.cn /english-satcnchuantongyixueldi7huichang.htm (last visited April 29, 2002).
218 id.
219 "With respect to customs duties and charges of any kind imposed on or in connection with
importation or exportation or imposed on the international transfer of payments for imports or exports...
any advantage, favour, privilege or immunity granted by any contracting party shall be accorded
immediately and unconditionally to the like product originating in or destined for the territories of all other
contracting parties." The General Agreement on Tariffs and Trade, Oct. 30, 1947, part I art. I [hereinafter
GATT] (see art. I for complete definition of MFN).
2o According to China's WTO accession tariff schedule, old tariffs for TCM items averaged 6%, and
post-accession tariffs average 3%. See China Accession Documents, Goods Schedule HS # 3001 &
30049020-9059 available at http://www.wto.org/english/thewto-e/acc.eprotocols-accmembership.e.htm
(last visited April 29, 2002). Although the decrease is significant proportionally, the actual monetary value
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membership that motivated passage of the vast array of TCM legislation.
The WTO political benefits of increased TCM legislation appear negligible.
However, other TCM providers were already WTO members; and China did
rely on its discretionary MFN status to stay in the market. Understandably,
WTO accession reduced worries of worldwide investors and traders of TCM
products that global TCM markets would become economically unprofitable
if China lost MFN status with its primary importers of TCM products.
China may feel that WTO membership will smooth its entry into the
global TCM market.22' GATIT2 22 nondiscriminatory import and export
requirements forced China to examine its discriminatory pharmaceutical
related laws.223 Theoretically, WTO membership should break down
protective tariffs and non-tariff barriers inhibiting the trade and development
of TCM products. Despite the revolutionary TCM related legislation passed
in China, some medical organizations already express concerns with
regulations that encourage import substitution and, de facto, violate sections
of GATT 224
Intellectual property protection also remains a crucial issue for the
Chinese, largely because of WTO requirements225. SATCM has supported
226increased intellectual property protection within China. Better protection
is negotiable and the tariff reduction was effective immediately indicating a lack of perceived need for
protection of the domestic TCM market. Id.
221 Health Minister Vows Support for Traditional Chinese Medicine, supra note 9. See also World
Economic Forum, Health: China's Next High Growth Industry, at http://www.weforum.org
2z2 GATT, supra note 219 (amended 1994). See http://www.wto.org (English translation of GATT
1994 available online as well as China's WTO accession agreements) (last visited Mar. 26, 2002).
223 Sec. 11 Economic Policies, Part 23:
The representative of China confirmed that measures would be taken at national and
sub-national level, including repeal or modification of legislation, to provide full GATT
national treatment in respect of laws, regulations and other measures applying to internal
sale, offering for sale, purchase, transportation, distribution or use of the following....
Pharmaceutical products, including regulations, notices and measures which subjected
imported pharmaceuticals to distinct procedures and formulas for pricing and
classification, or which set limits on profit margins attainable and imports, or which
created any other conditions regarding price or local content which could result in less
favourable treatment of imported products.
While the working party and the Chinese representative both recognized the potential problem in
pharmaceutical, including TCM, the eventual success of this agreement is still unpredictable. WTO
Ministeral Conference, Fourth Session Doha, 9-13 November 2001 Report of the Working Party on the
Accession of China 4 (Nov. 10, 2001).
22A Pharmaceutical Research and Manufacturers of America, Barriers to Market Access for Patented
Pharmaceutical Products, Issues Around the World, Watch Country: China, available at
http://www.phrma.org/policy/aroundworld/special30l/china.phtl (last visited April 18, 2002).
225 Thomas T. Moga, China Changes Patent Law to Comply with TRIPS, NAT'L L.J., July 23, 2001 at
C15.
2 Experts Call for Protection of Traditional Chinese Medicine, supra note 125.
PACIFIC RIM LAW & POLICY JOURNAL
for patentees will not only reward Chinese creation of TCM products, it will
also encourage foreign investment. Enforcing patent rights could also
encourage standardization in the final products. Only products complying
with accepted patents are protected, which motivates producers to
standardize medicines. Product quality issues could then be avoided both
internally and externally.2 27
It is reasonable to think that regulation and enforcement, even in the
short-term, will result in a change in the perception and attitudes of the
Chinese people, manufacturers, and foreign investors. There is reason for
cautious enthusiasm for the domestic and global future of TCM products
from China.228
V. EXPECTATIONS
The growing popularity of TCM in the international community is
unquestioned. Increased faith in TCM treatments is evidenced by the
willingness of insurance companies to cover TCM treatments and increased
use of TCM in international hospitals. Moreover, the United States, U.K.
and Australia have opened their own TCM schools. Largely focusing on
acupuncture, massage therapy and herbal tonics, these institutes turn out
medical assistants capable of aiding patients in relief of pain and symptoms.
Furthermore, TCM offers hope AIDS and cancer patients. TCM also offers
comfort without continual worries about side effects. Consequently, it
appears that the global popularity of TCM will continue to increase.
Clearly, China holds the home advantage for the research and
development of TCM products. Documentation of traditional remedies
known in isolated areas of China is encouraged. Urban TCM institutes are
also actively researching little known TCM treatments. Isolated territories
are encouraged to legitimize practice of local TCM therapy. Regional laws
on TCM production indicate that local areas are increasingly recognizing
their potential for profit from their local heritage. Hopefully, as more local
attention is paid to this valuable national resource, self-regulation, and
genuine scientific interests will flourish.
227 id.
2n Moga, supra note 225.
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